MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27Kip1 and p18INK4C) mutations

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 24, Issue 3, 2010, Pages 425-437

  Georgitsi, Marianthi ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

CDKN1B p27Kip1; CDKN2C p18INK4C; cyclin dependent kinase inhibitors (CDKIs); endocrine tumours; multiple endocrine neoplasia type 4 (MEN4)

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2C;

CARCINOGENESIS; ENDOCRINE TUMOR; ENZYME INACTIVATION; GENE MUTATION; HUMAN; MEDICAL LITERATURE; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLE ENDOCRINE NEOPLASIA TYPE 4; NONHUMAN; REVIEW;

ANIMALS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE MODELS, ANIMAL; GENETIC VARIATION; HAPLOINSUFFICIENCY; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROID NEOPLASMS;

EID: 77956581284     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2010.01.001     Document Type: Review

References (101)

1. S.K. Agarwal, M.B. Kester, and L.V. Debelenko Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states Human Molecular Genetics 6 1997 1169 1175
2. J.H. Bassett, S.A. Forbes, and A.A. Pannett Characterization of mutations in patients with multiple endocrine neoplasia type 1 American Journal of Human Genetics 62 1998 232 244
3. S. Giraud, C.X. Zhang, and O. Serova-Sinilnikova Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders American Journal of Human Genetics 63 1998 455 467
4. N. Hai, N. Aoki, and A. Shimatsu Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1 Clinical Endocrinology 52 2000 509 518
5. A. Cebrian, S. Ruiz-Llorente, and A. Cascon Mutational and gross deletion study of the MEN1 gene and correlation with clinical features in Spanish patients Journal of Medical Genetics 40 2003 e72
6. S. Ellard, A.T. Hattersley, and C.M. Brewer Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing Clinical Endocrinology 62 2005 169 175
7. R.D. Klein, S. Salih, and J. Bessoni Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory Genetics in Medicine 7 2005 131 138
8. M.C. Lemos, and R.V. Thakker Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene Human Mutation 29 2008 22 32
9. J.R. Burgess, B. Nord, and R. David Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1) Clinical Endocrinology 53 2000 205 211
10. N.S. Pellegata, L. Quintanilla-Martinez, and H. Siggelkow Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans Proceedings of the National Academy of Sciences of the United States of America 103 2006 15558 15563
11. A. Fritz, A. Walch, and K. Piotrowska Recessive transmission of a multiple endocrine neoplasia syndrome in the rat Cancer Research 62 2002 3048 3051
12. K. Nakayama, N. Ishida, and M. Shirane Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors Cell 85 1996 707 720
13. H. Kiyokawa, R.D. Kineman, and K.O. Manova-Todorova Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1) Cell 85 1996 721 732
14. M.L. Fero, M. Rivkin, and M. Tasch A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice Cell 85 1996 733 744
15. R. Morosetti, N. Kawamata, and A.F. Gombart Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma Blood 86 1995 1924 1930
16. K. Polyak The p27Kip1 tumor suppressor gene: still a suspect or proven guilty? Cancer Cell 10 2006 352 354
17. M. Georgitsi, A. Raitila, and A. Karhu Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia The Journal of Clinical Endocrinology and Metabolism 92 2007 3321 3325
18. S.K. Agarwal, C.M. Mateo, and S.J. Marx Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states The Journal of Clinical Endocrinology and Metabolism 94 2009 1826 1834
19. A. Falchetti, and M.L. Brandi Multiple endocrine neoplasia type I variants and phenocopies: more than a nosological issue? The Journal of Clinical Endocrinology and Metabolism 94 2009 1518 1520
20. A. Ozawa, S.K. Agarwal, and C.M. Mateo The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations The Journal of Clinical Endocrinology and Metabolism 92 2007 1948 1951
21. M. Owens, K. Stals, and S. Ellard Germline mutations in the CDKN1B gene encoding p27 Kip1 are a rare cause of multiple endocrine neoplasia type 1 Clinical Endocrinology 70 2009 499 500
22. S. Igreja, H.S. Chahal, and S.A. Akker Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations Clinical Endocrinology 70 2009 259 264
23. N. Hai, N. Aoki, and A. Matsuda Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1 (MEN1) European Journal of Endocrinology 141 1999 475 480
24. M.R. Pollak, E.M. Brown, and Y.H. Chou Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism Cell 75 1993 1297 1303
25. J.D. Carpten, C.M. Robbins, and A. Villablanca HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome Nature Genetics 32 2002 676 680
26. O. Vierimaa, M. Georgitsi, and R. Lehtonen Pituitary adenoma predisposition caused by germline mutations in the AIP gene Science 312 2006 1228 1230
27. O. Vierimaa, A. Villablanca, and A. Alimov Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition Journal of Endocrinological Investigation 32 2009 512 518
28. S. Takeuchi, H.P. Koeffler, and D.R. Hinton Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors The Journal of Endocrinology 157 1998 337 341
29. P.L. Dahia, R.C. Aguiar, and J. Honegger Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours Oncogene 16 1998 69 76
30. H. Ikeda, T. Yoshimoto, and N. Shida Molecular analysis of p21 and p27 genes in human pituitary adenomas British Journal of Cancer 76 1997 1119 1123
31. D. Lindberg, G. Akerstrom, and G. Westin Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function Neoplasia 9 2007 533 535
32. M.L. Fero, E. Randel, and K.E. Gurley The murine gene p27Kip1 is haplo-insufficient for tumour suppression Nature 396 1998 177 180
33. Y. Sato, Y. Suto, and J. Pietenpol TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies Blood 86 1995 1525 1533
34. H. Komuro, M.B. Valentine, and J.E. Rubnitz p27KIP1 deletions in childhood acute lymphoblastic leukemia Neoplasia 1 1999 253 261
35. E. Le Toriellec, G. Despouy, and G. Pierron Haploinsufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemia Blood 111 2008 2321 2328
36. R.V. Lloyd, L.A. Erickson, and L. Jin P27kip1: a Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers The American Journal of Pathology 154 1999 313 323
37. A. Sgambato, A. Cittadini, and B. Faraglia Multiple functions of p27(Kip1) and its alterations in tumor cells: a review Journal of Cellular Physiology 183 2000 18 27
38. I.M. Chu, L. Hengst, and J.M. Slingerland The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy Nature Reviews Cancer 8 2008 253 267
39. N. Kawamata, R. Morosetti, and C.W. Miller Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies Cancer Research 55 1995 2266 2269
40. K.S. Spirin, J.F. Simpson, and S. Takeuchi p27/Kip1 mutation found in breast cancer Cancer Research 56 1996 2400 2404
41. M. Pagano, S.W. Tam, and A.M. Theodoras Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 Science 269 1995 682 685
42. J. Slingerland, and M. Pagano Regulation of the cdk inhibitor p27 and its deregulation in cancer Journal of Cellular Physiology 183 2000 10 17
43. J. Philipp-Staheli, S.R. Payne, and C.J. Kemp p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer Experimental Cell Research 264 2001 148 168
44. J. Vervoorts, and B. Luscher Post-translational regulation of the tumor suppressor p27(KIP1) Cellular and Molecular Life Sciences 65 2008 3255 3264
45. G. Viglietto, M.L. Motti, and P. Bruni Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer Nature Medicine 8 2002 1136 1144
46. C. Catzavelos, N. Bhattacharya, and Y.C. Ung Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer Nature Medicine 3 1997 227 230
47. S. Takeuchi, C.R. Bartram, and C.W. Miller Acute lymphoblastic leukemia of childhood: identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1 Blood 87 1996 3368 3374
48. S. Takeuchi, N. Mori, and M. Koike Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12 Cancer Research 56 1996 738 740
49. Y. Hatta, S. Takeuchi, and J. Yokota Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes British Journal of Cancer 75 1997 1256 1262
50. A.S. Kibel, D. Freije, and W.B. Isaacs Deletion mapping at 12p12-13 in metastatic prostate cancer Genes, Chromosomes & Cancer 25 1999 270 276
51. J.C. Wilson, J.J. Zhu, and P.M. Black The p27/Kip1 locus shows no loss of heterozygosity in human pituitary adenomas Journal of Neuro-oncology 44 1999 35 39
52. X. Qian, L. Jin, and E. Kulig DNA methylation regulates p27kip1 expression in rodent pituitary cell lines The American Journal of Pathology 153 1998 1475 1482
53. D. Lindberg, G. Akerstrom, and G. Westin Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours Clinical Endocrinology 68 2008 271 277
54. A. Yoshino, Y. Katayama, and A. Ogino Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas Journal of Neuro-oncology 83 2007 153 162
55. L. Jin, X. Qian, and E. Kulig Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries The American Journal of Pathology 151 1997 509 519
56. R.V. Lloyd, L. Jin, and X. Qian Aberrant p27kip1 expression in endocrine and other tumors The American Journal of Pathology 150 1997 401 407
57. K. Lidhar, M. Korbonits, and S. Jordan Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors The Journal of Clinical Endocrinology and Metabolism 84 1999 3823 3830
58. C.M. Bamberger, M. Fehn, and A.M. Bamberger Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas European Journal of Endocrinology 140 1999 250 255
59. E. Heliovaara, A. Raitila, and V. Launonen The Expression of AIP-Related Molecules in Elucidation of Cellular Pathways in Pituitary Adenomas The American Journal of Pathology 175 2009 2501 2507
60. L.A. Erickson, L. Jin, and P.C. Wollan Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors Modern Pathology 11 1998 169 174
61. L.A. Erickson, L. Jin, and P. Wollan Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein The American Journal of Surgical Pathology 23 1999 288 295
62. Corbetta S, Vaira V, Guarnieri V et al. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocrine-Related Cancer 2009; (in press).
63. G. Canavese, C. Azzoni, and S. Pizzi P27: a Potential Main Inhibitor of Cell Proliferation in Digestive Endocrine Tumors but Not a Marker of Benign Behavior Human Pathology 32 2001 1094 1101
64. P. Grabowski, J. Schrader, and J. Wagner Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors Clinical Cancer Research 14 2008 7378 7384
65. P.C. Buchwald, G. Akerstrom, and G. Westin Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism Clinical Endocrinology 60 2004 389 393
66. C.J. Sherr, and J.M. Roberts CDK inhibitors: positive and negative regulators of G1-phase progression Genes & Development 13 1999 1501 1512
67. R.A. Weinberg The retinoblastoma protein and cell cycle control Cell 81 1995 323 330
68. S.L. Asa, and S. Ezzat The pathogenesis of pituitary tumours Nature Reviews Cancer 2 2002 836 849
69. S.A. Boikos, and C.A. Stratakis Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis Human Molecular Genetics 16 2007 R80 R87
70. K. Polyak, J.Y. Kato, and M.J. Solomon p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest Genes & Development 8 1994 9 22
71. K. Polyak, M.H. Lee, and H. Erdjument-Bromage Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals Cell 78 1994 59 66
72. S.K. Karnik, C.M. Hughes, and X. Gu Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c Proceedings of the National Academy of Sciences of the United States of America 102 2005 14659 14664
73. T.A. Milne, C.M. Hughes, and R. Lloyd Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors Proceedings of the National Academy of Sciences of the United States of America 102 2005 749 754
74. C.M. Hughes, O. Rozenblatt-Rosen, and T.A. Milne Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus Molecular Cell 13 2004 587 597
75. A. Yokoyama, Z. Wang, and J. Wysocka Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression Molecular and Cellular Biology 24 2004 5639 5649
76. K. Horiguchi, M. Yamada, and T. Satoh Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue Clinical Cancer Research 15 2009 2620 2629
77. M.B. Lodish, and C.A. Stratakis RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer Expert Review of Anticancer Therapy 8 2008 625 632
78. M. Drosten, G. Hilken, and M. Bockmann Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma Journal of the National Cancer Institute 96 2004 1231 1239
79. P.P. Joshi, M.V. Kulkarni, and B.K. Yu Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis Oncogene 26 2007 554 570
80. D. Vitagliano, F. Carlomagno, and M.L. Motti Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells Cancer Research 64 2004 3823 3829
81. M. Vargiolu, D. Fusco, and I. Kurelac The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability The Journal of Clinical Endocrinology and Metabolism 94 2009 2571 2578
82. A.F. Daly, J.F. Vanbellinghen, and S.K. Khoo Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families The Journal of Clinical Endocrinology and Metabolism 92 2007 1891 1896
83. B.K. Meyer, M.G. Pray-Grant, and J.P. Vanden Heuvel Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity Molecular and Cellular Biology 18 1998 978 988
84. S.K. Kolluri, C. Weiss, and A. Koff p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells Genes & Development 13 1999 1742 1753
85. H. Tahara, A.P. Smith, and R.D. Gaz Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate Journal of Bone and Mineral Research 12 1997 1330 1334
86. M. Kirsch, M. Morz, and T. Pinzer Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas Genes, Chromosomes & Cancer 48 2009 143 154
87. D.G. Morris, M. Musat, and S. Czirjak Differential gene expression in pituitary adenomas by oligonucleotide array analysis European Journal of Endocrinology 153 2005 143 151
88. M.G. Hossain, T. Iwata, and N. Mizusawa Expression of p18(INK4C) is down-regulated in human pituitary adenomas Endocrine Pathology 20 2009 114 121
89. K.P. Yang, C.V. Nguyen, and S.G. Castillo Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA Anticancer Research 10 1990 527 533
90. D.J. Marsh, G. Theodosopoulos, and K. Martin-Schulte Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma The Journal of Clinical Endocrinology and Metabolism 88 2003 1866 1872
91. W. van Veelen, R. Klompmaker, and M. Gloerich P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development International Journal of Cancer 124 2009 339 345
92. W. van Veelen, C.J. van Gasteren, and D.S. Acton Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development Cancer Research 68 2008 1329 1337
93. T. Jacks, A. Fazeli, and E.M. Schmitt Effects of an Rb mutation in the mouse Nature 359 1992 295 300
94. B.O. Williams, E.M. Schmitt, and L. Remington Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences The EMBO Journal 13 1994 4251 4259
95. D.S. Franklin, V.L. Godfrey, and H. Lee CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis Genes & Development 12 1998 2899 2911
96. D.S. Franklin, V.L. Godfrey, and D.A. O'Brien Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity Molecular and Cellular Biology 20 2000 6147 6158
97. L.T. Teixeira, H. Kiyokawa, and X.D. Peng p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation Oncogene 19 2000 1875 1884
98. A. Besson, H.C. Hwang, and S. Cicero Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype Genes & Development 21 2007 1731 1746
99. F. Bai, X.H. Pei, and V.L. Godfrey Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis Molecular and Cellular Biology 23 2003 1269 1277
100. F. Bai, X.H. Pei, and T. Nishikawa p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors Molecular and Cellular Biology 27 2007 1495 1504
101. X.H. Pei, F. Bai, and M.D. Smith p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers Cancer Research 67 2007 3162 3170